| answer text |
<p>The National Institute for Health and Care Excellence (NICE) makes recommendations
for the National Health Service in England on whether all new licensed medicines represent
a clinically effective and cost-effective use of NHS resources. NICE has been able
to recommend several gene therapies for routine funding and they are now routinely
available to NHS patients in line with NICE’s recommendations. No gene therapies have
been recommended for use through the Innovative Medicines Fund and NICE continues
to consider the suitability of medicines for the Fund with individual companies.</p>
|
 |
